COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Two cyclooxygenase isozymes, COX-1 and -2, are known to catalyze the rate-limiting step of prostaglandin synthesis and are the targets of nonsteroidal antiinflammatory drugs. Here we describe a third distinct COX isozyme, COX-3, as well as two smaller COX-1-derived proteins ( p artial COX-1 or PCOX-1 proteins). COX-3 and one of the PCOX-1 proteins (PCOX-1a) are made from the COX-1 gene but retain intron 1 in their mRNAs. PCOX-1 proteins additionally contain an in-frame deletion of exons 5–8 of the COX-1 mRNA. COX-3 and PCOX mRNAs are expressed in canine cerebral cortex and in lesser amounts in other tissues analyzed. In human, COX-3 mRNA is expressed as an ≈5.2-kb transcript and is most abundant in cerebral cortex and heart. Intron 1 is conserved in length and in sequence in mammalian COX-1 genes. This intron contains an ORF that introduces an insertion of 30–34 aa, depending on the mammalian species, into the hydrophobic signal peptide that directs COX-1 into the lumen of the endoplasmic reticulum and nuclear envelope. COX-3 and PCOX-1a are expressed efficiently in insect cells as membrane-bound proteins. The signal peptide is not cleaved from either protein and both proteins are glycosylated. COX-3, but not PCOX-1a, possesses glycosylation-dependent cyclooxygenase activity. Comparison of canine COX-3 activity with murine COX-1 and -2 demonstrates that this enzyme is selectively inhibited by analgesic/antipyretic drugs such as acetaminophen, phenacetin, antipyrine, and dipyrone, and is potently inhibited by some nonsteroidal antiinflammatory drugs. Thus, inhibition of COX-3 could represent a primary central mechanism by which these drugs decrease pain and possibly fever.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although subsequent studies largely failed to confirm a clinically relevant role for COX-3 in humans, the concept stimulated broader exploration of central nervous system (CNS) mechanisms underlying paracetamol-induced analgesia [ 26 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [26]
In the citing paper
“Early investigations, including work by Flower and Vane in the early 1970’s suggested that paracetamol exerted its effects through central inhibition of prostaglandin synthesis, leading to the proposal of a putative COX-3 isoform as a specific molecular target.”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [26]
In the citing paper
“a splice variant of COX-1, derived from the same gene, was characterized in dog brain which was sensitive to inhibition with paracetamol (48); it was designated COX-3 (48)”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [48]
In the citing paper
“Paracetamol showed selectivity for inhibition of COX-3 (IC 50 = 460 µM) over COX-1 and COX-2, which was dependent on the concentration of the substrate arachidonic acid suggesting competitive blockage at the active site [36].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [36]
In the citing paper
“Indeed, in 2002 a catalytically functional third COX enzyme was identified and was originally referred to as COX-3 by Professor Daniel Simmons's laboratory [36] and was referred to COX-1b in some publications [37][38][39][40].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [36]
Citations
Cites
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Self-citationWarner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
FLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779
Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
Riendeau, D., Percival, M. D., Brideau, C., Charleson, S., Dubé, D., Ethier, D., Falgueyret, J.-P., Friesen, R. W., Gordon, R., Greig, G., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38776-2 · Cited by 460
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350
Ketorolac: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential
Buckley, M. M.-T., & Brogden, R. N. (1990) · Drugs · doi:10.2165/00003495-199039010-00008 · Cited by 348
A radioimmunoassay for 6-keto- prostaglandin F1α
Simon, J. A. (1978) · Prostaglandins · doi:10.1016/0090-6980(78)90122-3 · Cited by 317
Identification of a phorbol ester-repressible v-src-inducible gene.
Simmons, D. L., Levy, D. B., Yannoni, Y., & Erikson, R. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1178 · Cited by 316
Self-citation
Research works printed but not linked: 3
- J Sambrook, D Russell Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab. Press, 3rd Ed., Plainview, NY, 2001).
- M A Moyad Semin Urol Oncol 19, 280–293 (2001).
- D Riendeau, M D Percival, C Brideau, S Charleson, D Dube, D Ethier, J P Falgueret, R W Friesen, R Gordon, G Greig, et al. J Pharmacol Exp Ther 296, 558–566 (2001).
Cited by
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Bhardwaj, A., Kaur, J., Wuest, M., & Wuest, F. (2017) · Nature Communications · doi:10.1038/s41467-016-0009-6 · Cited by 7,448
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
The Immunomodulatory and Anti-Inflammatory Role of Polyphenols
Yahfoufi, N., Alsadi, N., Jambi, M., & Matar, C. (2018) · Nutrients · doi:10.3390/nu10111618 · Cited by 1,737
“Cyclooxygenase (COX) or lipoxygenase (LOX) metabolize it and produce, respectively, prostaglandins (PGs) and thromboxane A2 (TXA2) by COX, and hydroxyeicosatetraenoic acids and leukotrienes (LTs) by LOX [106].”
BackgroundInfluentialCyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Self-citationHussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Function of alternative splicing
Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2005) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,377
The mechanism of action of aspirin
Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
“A third form (COX-3) has also been reported [15], although recent studies indicate that this represents a splice variant of COX-1 that encodes a truncated protein lacking enzymatic activity [16].”
BackgroundHuman Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry
Khetan, S. K., & Collins, T. J. (2007) · Chemical Reviews · doi:10.1021/cr020441w · Cited by 1,145
Harirforoosh, S., Asghar, W., & Jamali, F. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3vw2f · Cited by 960
Endometrial receptivity markers, the journey to successful embryo implantation.
Achache, H., & Revel, A. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml004 · Cited by 952
“To date, three isoforms of COX have been reported, COX-1, COX-2 and COX-3 (Smith and Dewitt, 1996; Vane et al., 1998; Chandrasekharan et al., 2002).”
BackgroundROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
“The PTGS1 gene encodes for both COX-1 and COX-3 isoenzymes; however, COX-3 activity in humans remains unclear [177, 178].”
BackgroundProstaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Anti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Mechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Synopsis of arachidonic acid metabolism: A review
Hanna, V. S., & Hafez, E. A. A. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.03.005 · Cited by 596
Acetaminophen for osteoarthritis
Towheed, T., Maxwell, L., Judd, M., Catton, M., Hochberg, M. C., & Wells, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004257.pub2 · Cited by 563
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Wang, H., Oo Khor, T., Shu, L., Su, Z.-Y., Fuentes, F., Lee, J.-H., & Tony Kong, A.-N. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833026 · Cited by 529
Alternative splicing in disease and therapy
Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L. (2004) · Nature Biotechnology · doi:10.1038/nbt964 · Cited by 527
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
FitzGerald, G. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1225 · Cited by 518
Paracetamol (Acetaminophen): mechanisms of action
ANDERSON, B. J. (2008) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2008.02764.x · Cited by 497
Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management
Szczeklik, A., & Stevenson, D. D. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1487 · Cited by 491
The role of aspirin in cancer prevention
Thun, M. J., Jacobs, E. J., & Patrono, C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.199 · Cited by 481
Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
Hinz, B., Cheremina, O., & Brune, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-8506com · Cited by 478
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundToxicokinetics and toxicodynamics of ochratoxin A, an update
Ringot, D., Chango, A., Schneider, Y.-J., & Larondelle, Y. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.10.106 · Cited by 477
Phillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.002 · Cited by 459
The development of COX2 inhibitors
Flower, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1034 · Cited by 459
Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice
Jenkins, C., Costello, J., & Hodge, L. (2004) · BMJ · doi:10.1136/bmj.328.7437.434 · Cited by 451
Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases
Sonnweber, T., Pizzini, A., Nairz, M., Weiss, G., & Tancevski, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113285 · Cited by 440
Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed
Dinarello, C. A. (2004) · Journal of Endotoxin Research · doi:10.1179/096805104225006129 · Cited by 435
Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Bacchi, S., Palumbo, P., Sponta, A., & Coppolino, M. F. (2012) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152312803476255 · Cited by 433
Arachidonic Acid Metabolism and Kidney Inflammation
Wang, T., Fu, X., Chen, Q., Patra, J. K., Wang, D., Wang, Z., & Gai, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153683 · Cited by 430
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
“Whereas COX-1 acetylation leads to a loss of its activity, the acetylated form of COX-2 leads to the synthesis of AT-LxA4, primarily identified to limit neutrophil activation and recruitment to inflamed tissues (Serhan et al., 2002) with anti-inflammatory and proresolving activities (Ye et al., 2010; Martins et al., 2…”
BackgroundInfluentialBenamouzig, R., Deyra, J., Martin, A., Girard, B., Jullian, E., Piednoir, B., Couturier, D., Coste, T., Little, J., & Chaussade, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00887-4 · Cited by 395
Cyclooxygenases in cancer: progress and perspective
Zha, S., Yegnasubramanian, V., Nelson, W. G., Isaacs, W. B., & De Marzo, A. M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.014 · Cited by 389
Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties
Yoon, J.-H., & Baek, S. J. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.5.585 · Cited by 381
Angiogenesis and hepatocellular carcinoma
Semela, D., & Dufour, J.-F. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.006 · Cited by 372
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
Yarla, N. S., Bishayee, A., Sethi, G., Reddanna, P., Kalle, A. M., Dhananjaya, B. L., Dowluru, K. S. V. G. K., Chintala, R., & Duddukuri, G. R. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.02.001 · Cited by 364
The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
Sobolewski, C., Cerella, C., Dicato, M., Ghibelli, L., & Diederich, M. (2010) · International Journal of Cell Biology · doi:10.1155/2010/215158 · Cited by 354
Cyclooxygenases, prostanoids, and tumor progression
Wang, M.-T., Honn, K. V., & Nie, D. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9096-5 · Cited by 345
COX-2 as a target for cancer chemotherapy
Ghosh, N., Chaki, R., Mandal, V., & Mandal, S. C. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70262-0 · Cited by 344
Fever and hypothermia in systemic inflammation: recent discoveries and revisions
Romanovsky, A. (2005) · Frontiers in Bioscience · doi:10.2741/1690 · Cited by 344
Topical and Peripherally Acting Analgesics
Sawynok, J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.1 · Cited by 344
Adverse Cardiovascular Effects of the Coxibs
Dogné, J.-M., Supuran, C. T., & Pratico, D. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0402059 · Cited by 344
Cyclooxygenase-2 and prostaglandins in articular tissues
Martel-Pelletier, J., Pelletier, J.-P., & Fahmi, H. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(03)00134-3 · Cited by 333
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
Gasparini, G., Longo, R., Sarmiento, R., & Morabito, A. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01220-8 · Cited by 330
The Role of Biomechanics and Inflammation in Cartilage Injury and Repair
Guilak, F., Fermor, B., Keefe, F. J., Kraus, V. B., Olson, S. A., Pisetsky, D. S., Setton, L. A., & Weinberg, J. B. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000131233.83640.91 · Cited by 325
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
Chan, A. T., Manson, J. E., Albert, C. M., Chae, C. U., Rexrode, K. M., Curhan, G. C., Rimm, E. B., Willett, W. C., & Fuchs, C. S. (2006) · Circulation · doi:10.1161/circulationaha.105.595793 · Cited by 319
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Single dose oral paracetamol (acetaminophen) for postoperative pain in adults
Toms, L., McQuay, H. J., Derry, S., & Moore, R. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004602.pub2 · Cited by 311
LEES, P., LANDONI, M. F., Giraudel, J., & TOUTAIN, P. L. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00617.x · Cited by 310
Unuofin, J. O., & Lebelo, S. L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1356893 · Cited by 308
Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?
Warner, T. D., & Mitchell, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222543099 · Cited by 302
Regulation of Cerebral Blood Flow
Peterson, E. C., Wang, Z., & Britz, G. (2011) · International Journal of Vascular Medicine · doi:10.1155/2011/823525 · Cited by 302
The COX-2 pathway is essential during early stages of skeletal muscle regeneration
Bondesen, B. A., Mills, S. T., Kegley, K. M., & Pavlath, G. K. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00088.2004 · Cited by 300
Zimmermann, N., Wenk, A., Kim, U., Kienzle, P., Weber, A.-A., Gams, E., Schrör, K., & Hohlfeld, T. (2003) · Circulation · doi:10.1161/01.cir.0000081770.51929.5a · Cited by 287
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn
Antonucci, R., Zaffanello, M., Puxeddu, E., Porcella, A., Cuzzolin, L., Dolores Pilloni, M., & Fanos, V. (2012) · Current Drug Metabolism · doi:10.2174/138920012800166607 · Cited by 275
NIH Consensus Statement on Total Knee Replacement December 8-10, 2003*
(2004) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200406000-00030 · Cited by 269
Mechanism of Free Radical Oxygenation of Polyunsaturated Fatty Acids by Cyclooxygenases
Rouzer, C. A., & Marnett, L. J. (2003) · Chemical Reviews · doi:10.1021/cr000068x · Cited by 266
Renal adverse effects of nonsteroidal anti-inflammatory drugs
Harirforoosh, S., & Jamali, F. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903311023 · Cited by 261
Inflammatory effects of snake venom myotoxic phospholipases A2
Teixeira, C. F. P., Landucci, E. C. T., Antunes, E., Chacur, M., & Cury, Y. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.006 · Cited by 260
Burian, M., & Geisslinger, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.004 · Cited by 259
Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews
Moore, R. A., Derry, S., Aldington, D., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659.pub3 · Cited by 258
Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
Kis, B., Snipes, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085431 · Cited by 250
“COX-3 was first described in dogs as an alternative splice variant of COX-1 (Chandrasekharan et al., 2002).”
BackgroundMethodResultInfluentialBazan, N. G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300013-jlr200 · Cited by 247
Differences in signaling pathways by IL-1β and IL-18
Lee, J.-K., Kim, S.-H., Lewis, E. C., Azam, T., Reznikov, L. L., & Dinarello, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402800101 · Cited by 237
Endothelial influences on cerebrovascular tone
Andresen, J., Shafi, N. I., & Bryan, R. M. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00937.2005 · Cited by 235
Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke
Rink, C., & Khanna, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3474 · Cited by 233
Gasparini, L., Ongini, E., & Wenk, G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02743.x · Cited by 226
ARONOFF, D., OATES, J., & BOUTAUD, O. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.009 · Cited by 222
Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action
Ohashi, N., & Kohno, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.580289 · Cited by 223
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
Nonsteroidal anti-inflammatory drugs in cats: a review
Lascelles, B. D. X., Court, M. H., Hardie, E. M., & Robertson, S. A. (2007) · Veterinary Anaesthesia and Analgesia · doi:10.1111/j.1467-2995.2006.00322.x · Cited by 203
Single dose oral analgesics for acute postoperative pain in adults
Moore, R. A., Derry, S., McQuay, H. J., & Wiffen, P. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659.pub2 · Cited by 198
Cyclooxygenase-2 in synaptic signaling
Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195
Paracetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190
“Since they are highly polar, the tested drugs are unlikely to reach brain COX-3 in effective concentrations.20 Another feature of COX-3 is the localization of expression.36 Initially, Chandrasekharan et al (2002) assumed that the enzyme was expressed in the cerebral cortex and heart.”
BackgroundInfluentialCyclooxygenase enzymes and prostaglandins in pathology of the endometrium
Sales, K. J., & Jabbour, H. N. (2003) · Reproduction · doi:10.1530/rep.0.1260559 · Cited by 177
“Three isoforms of COX enzyme (COX-1, COX-2 and COX-3) catalyse the commited step in prostanoid biosynthesis (Chandrasekharan et al., 2002; Morita, 2002).”
BackgroundNon-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews
Moore, R. A., Wiffen, P. J., Derry, S., Maguire, T., Roy, Y. M., & Tyrrell, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010794.pub2 · Cited by 174
Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain
Derry, C. J., Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010210.pub2 · Cited by 173
Teeling, J. L., Cunningham, C., Newman, T. A., & Perry, V. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.11.006 · Cited by 139
Toussaint, K., Yang, X. C., Zielinski, M. A., Reigle, K. L., Sacavage, S. D., Nagar, S., & Raffa, R. B. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01143.x · Cited by 135
“However, COX-3 does not mediate antinociception in rats, COX-3 is not detected in humans, and the low expression level and kinetics make it is unlikely that COX-3 has clinical relevance for paracetamol’s mechanism of analgesic action (88).”
BackgroundInfluentialProstaglandins and sickness behavior: Old story, new insights
Pecchi, E., Dallaporta, M., Jean, A., Thirion, S., & Troadec, J.-D. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.040 · Cited by 135
De Caterina, R., & Massaro, M. (2005) · Journal of Membrane Biology · doi:10.1007/s00232-005-0783-2 · Cited by 130
Cerella, C., Sobolewski, C., Dicato, M., & Diederich, M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.050 · Cited by 129
Cellular mechanisms of acetaminophen: role of cyclo‐oxygenase
Lucas, R., Warner, T. D., Vojnovic, I., & Mitchell, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2437fje · Cited by 128
“In cyclo-oxygenase-3 this signal peptide is not cleaved, and the protein is glycosylated and displays cyclo-oxygenase activity (2).”
BackgroundInfluentialCristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., & Di Marzo, V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.047 · Cited by 115
Single dose oral paracetamol (acetaminophen) for postoperative pain
Barden, J., Edwards, J., Moore, A., & McQuay, H. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004602 · Cited by 113
Novel Aspects of Endothelium-Dependent Regulation of Vascular Tone
Villar, I. C., Francis, S., Webb, A., Hobbs, A. J., & Ahluwalia, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001680 · Cited by 112
Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion
Rose, J. W., Hill, K. E., Watt, H. E., & Carlson, N. G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.021 · Cited by 107
Ayoub, S. S., Botting, R. M., Goorha, S., Colville-Nash, P. R., Willoughby, D. A., & Ballou, L. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404185101 · Cited by 104
Metadata
- Authors
- Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L.
- Affiliations
- Brigham Young University (US)
- Corresponding author
- Simmons, Daniel L.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-09-19
- Volume
- 99
- Issue
- 21
- Pages
- 13926-13931
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC129799
- OpenAlex
- W2024289681
- Cited by
- 1,989
- References
- 41
- Citations by year
- 2026: 22 · 2025: 42 · 2024: 49 · 2023: 49 · 2022: 41 · 2021: 55 · 2020: 51 · 2019: 61 · 2018: 52 · 2017: 48 · 2016: 69 · 2015: 75 · 2014: 73 · 2013: 80 · 2012: 84
- FWCI
- 92.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brigham Young University
- National Institutes of Health (5r01ar046688-03)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR46688)
- Division of Mathematical Sciences
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- cyclooxygenase-1, paracetamol, analgesic-antipyretic drugs, nonsteroidal anti-inflammatory drugs, prostaglandin synthesis, intron 1, signal peptide, glycosylation, gene cloning, enzyme inhibition
- MeSH terms
- Acetaminophen, Animals, Aorta, Cerebral Cortex, Cloning, Molecular, Dogs, Humans, Isoenzymes, Membrane Proteins, Molecular Sequence Data, Prostaglandin-Endoperoxide Synthases, Recombinant Proteins, RNA, Messenger, Tissue Distribution, Genetic Variation, Molecular Structure, Cyclooxygenase Inhibitors, Analgesics, Non-Narcotic, Mice, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.